LakePharma Announces "New Frontiers in Biologics" as The Theme for Its Annual Protein Engineering Symposium in 2018


The Bay Area Annual Event Will Be Held on October 5th at the South San Francisco Conference Center

SAN CARLOS, Calif., Aug. 14, 2018 /PRNewswire/ -- LakePharma, the leading, US-based biologics company specializing in antibody and protein engineering, cell line development, and protein production, announced today the theme for its annual protein engineering conference: "New Frontiers in Biologics", to be held on Friday, October 5, 2018 at the South San Francisco Conference Center, CA.

The one-day LakePharma Symposium will cover topics such as latest advances in innovative technologies bringing about next generation gene and cell therapies. Organized by Hua Tu (LakePharma, CEO), Norman Garceau (LakePharma, VP), and Yuko Terasawa (Nanomolar, SVP), the symposium will feature distinguished industry and academic researchers such as Deepak Srivastata, President of Gladstone Institute; Steven Banerjee, CEO of Mekonos; Damien Bates, CMO of SanBio; Jordon Wang, VP of Antibody Discovery, LakePharma, -- to name a few.

"This is the sixth year LakePharma has organized the annual protein engineering symposium. We are proud to provide the platform for local scientists to learn and network with colleagues throughout the field," said Hua Tu, Ph.D, founder and CEO of LakePharma. "We look forward to seeing more researchers, more discussions, and more new partnerships formed as a result."

To view the symposium agenda and to register, click here.

About LakePharma
LakePharma is the leading US-based biologics company specializing in antibody engineering, antibody discovery, molecular engineering, protein chemistry, bioexpression, biofunction, bioprocessing, bioanalytics and µBIOMANUFACTURING? biologics manufacturing services for Phase 1 clinical trials. LakePharma focuses on integrated platforms to support projects throughout the drug discovery process. LakePharma offers dedicated client services and sophisticated software to provide real-time access to project data via a secure cloud-based portal. For more information, please visit

Walter Tian
VP, Commercial Operation


View original content with multimedia:

SOURCE LakePharma

Back to news